{"id":"https://openalex.org/W2170597465","doi":"https://doi.org/10.1016/s0924-977x(01)00077-3","title":"Nitric oxide synthase inhibitors cause motor deficits in mice","display_name":"Nitric oxide synthase inhibitors cause motor deficits in mice","publication_year":2001,"publication_date":"2001-04-01","ids":{"openalex":"https://openalex.org/W2170597465","doi":"https://doi.org/10.1016/s0924-977x(01)00077-3","mag":"2170597465","pmid":"https://pubmed.ncbi.nlm.nih.gov/11313158"},"language":"en","primary_location":{"id":"doi:10.1016/s0924-977x(01)00077-3","doi":"https://doi.org/10.1016/s0924-977x(01)00077-3","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0924-977x(01)00077-3","pdf_url":null,"source":{"id":"https://openalex.org/S168041952","display_name":"European Neuropsychopharmacology","issn_l":"0924-977X","issn":["0924-977X","1873-7862"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Neuropsychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059583115","display_name":"Tsutomu Araki","orcid":"https://orcid.org/0000-0001-5943-1145","observed_orcids":["https://orcid.org/0000-0001-5943-1145"]},"institutions":[{"id":"https://openalex.org/I201537933","display_name":"Tohoku University","ror":"https://ror.org/01dq60k83","country_code":"JP","type":"education","lineage":["https://openalex.org/I201537933"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Tsutomu Araki","raw_affiliation_strings":["Department of Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Science and Medicine, Aramaki, Aoba-ku, 980-8578, Sendai, Japan. tsuaraki@mail.cc.tohoku.ac.jp","Department of Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Science and Medicine, Aramaki, Aoba-ku, Sendai 980-8578, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Science and Medicine, Aramaki, Aoba-ku, 980-8578, Sendai, Japan. tsuaraki@mail.cc.tohoku.ac.jp","institution_ids":["https://openalex.org/I201537933"]},{"raw_affiliation_string":"Department of Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Science and Medicine, Aramaki, Aoba-ku, Sendai 980-8578, Japan","institution_ids":["https://openalex.org/I201537933"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Haruo Mizutani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093896","display_name":"Tohoku University Hospital","ror":"https://ror.org/00kcd6x60","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210093896"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Haruo Mizutani","raw_affiliation_strings":["Department of Pharmaceutical Sciences, Tohoku University Hospital, Sendai, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, Tohoku University Hospital, Sendai, Japan","institution_ids":["https://openalex.org/I4210093896"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000285722","display_name":"Mitsunobu Matsubara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I201537933","display_name":"Tohoku University","ror":"https://ror.org/01dq60k83","country_code":"JP","type":"education","lineage":["https://openalex.org/I201537933"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mitsunobu Matsubara","raw_affiliation_strings":["Second Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Second Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan","institution_ids":["https://openalex.org/I201537933"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008308259","display_name":"Yutaka Imai","orcid":"https://orcid.org/0000-0003-3925-8837","observed_orcids":["https://orcid.org/0000-0003-3925-8837"]},"institutions":[{"id":"https://openalex.org/I201537933","display_name":"Tohoku University","ror":"https://ror.org/01dq60k83","country_code":"JP","type":"education","lineage":["https://openalex.org/I201537933"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yutaka Imai","raw_affiliation_strings":["Department of Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Science and Medicine, Aramaki, Aoba-ku, Sendai 980-8578, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology and Therapeutics, Tohoku University Graduate School of Science and Medicine, Aramaki, Aoba-ku, Sendai 980-8578, Japan","institution_ids":["https://openalex.org/I201537933"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037682743","display_name":"Michinao Mizugaki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093896","display_name":"Tohoku University Hospital","ror":"https://ror.org/00kcd6x60","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210093896"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Michinao Mizugaki","raw_affiliation_strings":["Department of Pharmaceutical Sciences, Tohoku University Hospital, Sendai, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, Tohoku University Hospital, Sendai, Japan","institution_ids":["https://openalex.org/I4210093896"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111380662","display_name":"Yasuto Itoyama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I201537933","display_name":"Tohoku University","ror":"https://ror.org/01dq60k83","country_code":"JP","type":"education","lineage":["https://openalex.org/I201537933"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasuto Itoyama","raw_affiliation_strings":["Department of Neurology, Tohoku University School of Medicine, Sendai, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Tohoku University School of Medicine, Sendai, Japan","institution_ids":["https://openalex.org/I201537933"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5059583115"],"corresponding_institution_ids":["https://openalex.org/I201537933"],"apc_list":{"value":3000,"currency":"USD","value_usd":3000},"apc_paid":null,"fwci":1.477,"has_fulltext":false,"cited_by_count":52,"citation_normalized_percentile":{"value":0.79129037,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"11","issue":"2","first_page":"125","last_page":"133"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.5586000084877014,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.5586000084877014,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.16859999299049377,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.10790000110864639,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nitric-oxide-synthase-inhibitors","display_name":"nitric oxide synthase inhibitors","score":0.9779999852180481},{"id":"https://openalex.org/keywords/neuronal-nitric-oxide-synthase","display_name":"neuronal nitric oxide synthase","score":0.9319999814033508},{"id":"https://openalex.org/keywords/7-nitroindazole","display_name":"7-nitroindazole","score":0.9599999785423279},{"id":"https://openalex.org/keywords/l-name","display_name":"L-NAME","score":0.921999990940094},{"id":"https://openalex.org/keywords/motor-impairment","display_name":"motor impairment","score":0.7960000038146973},{"id":"https://openalex.org/keywords/catalepsy","display_name":"catalepsy","score":0.9810000061988831},{"id":"https://openalex.org/keywords/pole-test","display_name":"pole test","score":0.9700000286102295},{"id":"https://openalex.org/keywords/haloperidol","display_name":"haloperidol","score":0.9259999990463257},{"id":"https://openalex.org/keywords/dopamine-d2-receptor-antagonists","display_name":"dopamine D2 receptor antagonists","score":0.8989999890327454},{"id":"https://openalex.org/keywords/striatum","display_name":"striatum","score":0.7630000114440918},{"id":"https://openalex.org/keywords/dopamine","display_name":"dopamine","score":0.9210000038146973},{"id":"https://openalex.org/keywords/dopac","display_name":"DOPAC","score":0.9729999899864197},{"id":"https://openalex.org/keywords/homovanillic-acid","display_name":"homovanillic acid","score":0.9819999933242798},{"id":"https://openalex.org/keywords/l-arginine","display_name":"L-arginine","score":0.9649999737739563},{"id":"https://openalex.org/keywords/motor-behavior","display_name":"motor behavior","score":0.49799999594688416}],"concepts":[{"id":"https://openalex.org/C2775841634","wikidata":"https://www.wikidata.org/wiki/Q903566","display_name":"Homovanillic acid","level":4,"score":0.8601764440536499},{"id":"https://openalex.org/C2780948584","wikidata":"https://www.wikidata.org/wiki/Q251347","display_name":"Haloperidol","level":3,"score":0.7837430238723755},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.7508290410041809},{"id":"https://openalex.org/C2780476085","wikidata":"https://www.wikidata.org/wiki/Q918193","display_name":"Catalepsy","level":4,"score":0.7386808395385742},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6138136386871338},{"id":"https://openalex.org/C2777622882","wikidata":"https://www.wikidata.org/wiki/Q417619","display_name":"Nitric oxide synthase","level":3,"score":0.6020549535751343},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.597421407699585},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5570648908615112},{"id":"https://openalex.org/C2780062018","wikidata":"https://www.wikidata.org/wiki/Q1319792","display_name":"Striatum","level":3,"score":0.47697433829307556},{"id":"https://openalex.org/C44208683","wikidata":"https://www.wikidata.org/wiki/Q15335165","display_name":"Dopamine receptor D2","level":3,"score":0.4517868161201477},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.41842883825302124},{"id":"https://openalex.org/C519581460","wikidata":"https://www.wikidata.org/wiki/Q207843","display_name":"Nitric oxide","level":2,"score":0.3910600244998932},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37610045075416565},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.25306594371795654},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.20263278484344482},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.15847906470298767},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.10018467903137207}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001923","descriptor_name":"Brain Chemistry","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002375","descriptor_name":"Catalepsy","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004409","descriptor_name":"Dyskinesia, Drug-Induced","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":true},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007191","descriptor_name":"Indazoles","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009043","descriptor_name":"Motor Activity","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017072","descriptor_name":"Neostriatum","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017072","descriptor_name":"Neostriatum","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018492","descriptor_name":"Dopamine Antagonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019001","descriptor_name":"Nitric Oxide Synthase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D019331","descriptor_name":"NG-Nitroarginine Methyl Ester","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052248","descriptor_name":"Nitric Oxide Synthase Type I","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0924-977x(01)00077-3","doi":"https://doi.org/10.1016/s0924-977x(01)00077-3","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0924-977x(01)00077-3","pdf_url":null,"source":{"id":"https://openalex.org/S168041952","display_name":"European Neuropsychopharmacology","issn_l":"0924-977X","issn":["0924-977X","1873-7862"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Neuropsychopharmacology","raw_type":"journal-article"},{"id":"pmid:11313158","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11313158","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":42,"referenced_works":["https://openalex.org/W91492509","https://openalex.org/W264928753","https://openalex.org/W1965156670","https://openalex.org/W1965724203","https://openalex.org/W1966322594","https://openalex.org/W1968228025","https://openalex.org/W1974350895","https://openalex.org/W1976585673","https://openalex.org/W1976836056","https://openalex.org/W1979076998","https://openalex.org/W1979994394","https://openalex.org/W1981024710","https://openalex.org/W1987546105","https://openalex.org/W1988726352","https://openalex.org/W1992693719","https://openalex.org/W1999740538","https://openalex.org/W2001864292","https://openalex.org/W2010204734","https://openalex.org/W2025958644","https://openalex.org/W2028676745","https://openalex.org/W2035205866","https://openalex.org/W2037656223","https://openalex.org/W2038733394","https://openalex.org/W2040013286","https://openalex.org/W2046263998","https://openalex.org/W2047843548","https://openalex.org/W2062384458","https://openalex.org/W2064127705","https://openalex.org/W2065750772","https://openalex.org/W2067330736","https://openalex.org/W2067494203","https://openalex.org/W2068869692","https://openalex.org/W2073167767","https://openalex.org/W2077956774","https://openalex.org/W2080422256","https://openalex.org/W2089987432","https://openalex.org/W2117573289","https://openalex.org/W2124333932","https://openalex.org/W2136751004","https://openalex.org/W2153491246","https://openalex.org/W2155848526","https://openalex.org/W2405936046"],"related_works":["https://openalex.org/W1169018294","https://openalex.org/W1999524832","https://openalex.org/W2164784351","https://openalex.org/W7123357087","https://openalex.org/W1977428952","https://openalex.org/W2045417237","https://openalex.org/W4245212867","https://openalex.org/W1966172617","https://openalex.org/W7095855551","https://openalex.org/W2022979534"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}